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980 APRIL 2020RESEARCH LETTERSAngiotensin-converting enzyme and
subclinical atherosclerosis in
psoriasis: Is there any association?
A case-control studyTo the Editor: Psoriasis is an inflammatory skin disease
that may be associated with cardiovascular diseases
even without conventional risk factors, so the role of
various inflammatory factors has been investigated.1
Angiotensin-converting enzyme (ACE) is a potent
vasoconstrictor agent and degrades bradykinin as a
vasodilator.2 It plays an important role in normal
cutaneous homeostasis and is a regulatory factor in
controlling cutaneous inflammatory responses.
Studies have found an increased level of serum ACE
in patients with psoriasis.3 On the other hand, some
studies showed a positive association between the
ACE polymorphism and mean carotid intima-media
thickness (M-CIMT).4 These findings suggest that this
enzyme may play a role in the pathogenesis of
psoriasis and also subclinical atherosclerosis.
Increased CIMT can be considered an indicator of
generalized atherosclerosis independent of
conventional cardiovascular risk factors.5 In this
case-control study, we evaluated the association
between serum ACE level and subclinical
atherosclerosis in psoriatic patients without
underlying cardiovascular risk factors.
M-CIMT and the serum ACE levels of 61
patients with moderate to severe plaque type
psoriasis and 61 healthy control subjects who were














n carotid intima meSubclinical atherosclerosis was assessed using
high-resolution B mode duplex ultrasonography
and defined as having an M-CIMT $0.8 mm. Serum
ACE was measured by the kinetic method (Cobas
Mira Plus biochemistry analyzer, ACE kit; reference
value 8-52 U/L).
Baseline demographics, clinical features, labora-
tory findings, and M-CIMT of the 2 groups are
presented in Table I. The median serum ACE levels
in psoriatic patients were higher than in healthy
controls (P\.05). In addition, psoriatic patients had
significantly greater M-CIMT than healthy subjects
(Table I). Serum ACE level was positively correlated
with M-CIMT (Table II). Correlation between
M-CIMT and all other variables are shown in
Table II. Twenty-seven patients (44.3%) and none
of the healthy control subjects had subclinical
atherosclerosis. Eight (13.11%) patients had psoriatic
arthritis. In this group, serum ACE level
(45.11 6 19.01) and M-CIMT (0.4-1.1 mm) were
higher than psoriatic patients without psoriatic
arthritis, but it was not significant (Supplemental
Table I, available online at www.jaad.org).
Some studies have shown that themean serumACE
activity is significantly increased in patients with pso-
riasis compared with healthy subjects.3 Similarly, our
study showed that serum ACE level is significantly
increased in psoriasis. Consistent with previous
studies, we reported an increased serum ACE level
and M-CIMT in patients with chronic plaque type
psoriasis.3,5 Interestingly, our results showed ags, and mean carotid intima media thickness in
sis (n = 61) Healthy controls (n = 61) P value
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Table II. Correlation between mean carotid intima media thickness and all other variables
Variable
M-CIMT (mm)
Patients with psoriasis (n = 61) Healthy controls (n = 61)
r P value r P value
ACE, U/L 0.637 \.0001 0.389 .02
Age, years 0.495 \.0001 0.597 \.0001
Body mass index, kg/m2 0.069 .598 0.305 .017
Duration of disease 0.327 .01 — —
PASI score 0.39 .002 — —
ACE, Angiotensin-converting enzyme; M-CIMT, mean carotid intima media thickness; PASI, Psoriasis Area and Severity Index.
J AM ACAD DERMATOL
VOLUME 82, NUMBER 4
Research Letters 981significant correlation between ACE and M-CIMT.
Huskic et al3 suggested that damage to the blood
vessel endothelium in psoriasis can contribute to a
higher release of ACE from the vessels. Considering
the changes causedbyACEand the renineangiotensin
system, as well as the metabolic changes in vascular
endothelium, atherosclerosis may be accelerated in
patients with psoriasis. To our knowledge, this
investigation is the first study to evaluate the
relationship between subclinical atherosclerosis and
serum level of ACE in patients with psoriasis.
Finally, along with M-CIMT, serum ACE level
can be considered an indicator of subclinical
atherosclerosis in patients with psoriasis, particularly
in those with severe skin disease, but extensive
studies are needed to clarify this issue.Fahimeh Abdollahimajd, MD,a Nasim Niknezhad,
MD,a Hamid Reza Haghighatkhah, MD,b
Nastaran Namazi, MD,a Nakisa Niknejad, MD,c
and Atefeh Talebi, PhDd
Skin Research Center,a Shahid Beheshti University
of Medical Sciences, Tehran; Department of
Radiology and Medical Imaging Center,b Sho-
hada-e Tajrish Hospital, Shahid Beheshti Uni-
versity of Medical Sciences, Tehran; Department
of Pathology,c Imam Khomeini Hospital Com-
plex, Tehran University of Medical Sciences,
Tehran; and the Colorectal Research Center,d
Iran University of Medical Sciences, Tehran,
Iran.
Funding sources: None.
Conflicts of interest: None disclosed.
Reviewed and approved by Shahid Beheshti Uni-
versity of Medical Sciences Institutional Review
Board (IR.SBMU.SRC.REC.1394.9).
Correspondence to: Nastaran Namazi, MD, Skin
Research Center, Shahid Beheshti University of
Medical Sciences, Tehran 001, Iran
E-mail: nastaran.namazi.md@gmail.comREFERENCES
1. Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in
psoriasis. J Am Acad Dermatol. 2007;57:347-354.
2. Steckelings UM, Wollschlager T, Peters J, et al. Human skin:
source of and target organ for angiotensin II. Exp Dermatol.
2004;13:148-154.
3. Huskic J, Mulabegovic N, Alendar F, et al. Serum and tissue
angiotensin converting enzyme in patients with psoriasis. Coll
Antropol. 2008;32:1215-1219.
4. Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM,
Witteman JC. Angiotensin-converting enzyme gene polymor-
phism and carotid artery wall thickness: a meta-analysis.
Stroke. 2003;34:1634-1639.
5. Shahidi-Dadras M, Haghighatkhah HR, Abdollahimajd F, et al.
Correlation between vascular endothelial growth factor and
subclinical atherosclerosis in patients with psoriasis. Int J
Dermatol. 2016;55:52-59.Do patients clinically diagnosed
with vascular malformations of 1
lower extremity benefit from
imaging of both legs from pelvis to
toe? A prospective MRI study
To the Editor: The extent of vascular malformations
(VMs) varies and can be underestimated by clinical
examination.1 We performed a prospective study to
determine the value of magnetic resonance imaging
(MRI) of both legs in patients with a manifest VM
affecting 1 lower extremity.
All patients who visited our tertiary care Vascular
Anomalies Center during January 2012-October 2013
for interventional therapy of a VM involving a single
lower extremity were eligible for this institutional
review board-approved study. An interventional
radiologist with 16 years’ experience specializing in
VMs clinically examined the 100 enrolled patients.
An MRI (3.0 Tesla, Skyra, Siemens Healthcare,
Erlangen, Germany) was performed on both legs
from pelvis to toe according to a predetermined
protocol,2 and 2 radiologists (who were blinded to
the clinical data) evaluated these MRI images and
determined a consensus.
Patient groups and VM types were classified
according to the International Society for the Study
Supplemental Table I. Correlation between
mean carotid intima media thickness and serum
angiotensin-converting enzyme level in patients




arthritis (n = 8)
Psoriatic patients
without
arthritis (n = 53) P value
ACE level, U/L .084
Mean 6 SD 40.11 6 12.07 33.63 6 18.40
Range 23.40-60.20 10-88.40
M-CIMT, mm
Mean 6 SD 0.8 6 0.26 0.74 6 0.2 .542
Range 0.4-1.1 0.4-1.28
ACE, Angiotensin-converting enzyme; M-CIMT, mean carotid
intima media thickness; SD, standard deviation.
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